Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MORF4L2-AS1 mRNA | CTD | PMID:27188386 | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of MORF4L2-AS1 mRNA | CTD | PMID:31629900 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of MORF4L2-AS1 mRNA | CTD | PMID:25583101 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MORF4L2-AS1 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of MORF4L2-AS1 mRNA | CTD | PMID:34973136 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MORF4L2-AS1 mRNA | CTD | PMID:24383497 and PMID:26272509 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MORF4L2-AS1 mRNA | CTD | PMID:27188386 | |